Acquirer’s Multiple Stock $INGR Appearing In Dalio, Greenblatt, Einhorn Portfolios

Johnny HopkinsStock ScreenerLeave a Comment

Part of the weekly research here at The Acquirer’s Multiple features some of the top picks from our Stock Screeners and some top investors who are holding these same picks in their portfolios. Investors such as Warren Buffett, Joel Greenblatt, Carl Icahn, Jim Simons, Prem Watsa, Jeremy Grantham, Seth Klarman, Ray Dalio, and Howard Marks. The top investor data is provided from their latest 13F’s. This week we’ll take a look at:

Ingredion Inc (NYSE: INGR)

Ingredion manufactures ingredients for the food, beverage, paper, and personal-care industries. Sweeteners (syrups, maltodextrins, dextrose, and polyols) account for about 35% of sales, starches (for food and industrial use) around 45%, and co-products the balance. Value-added, specialty ingredients account for nearly one third of sales, with the balance being commodity-grade ingredients. With the majority of sales outside the U.S., Ingredion is a global player with good exposure to developing markets, including Latin America and Asia-Pacific.

A quick look at the price chart below for Ingredion shows us that the stock is down 13% in the past twelve months. We currently have the stock trading on an Acquirer’s Multiple of 10.26, which means that it remains undervalued.

(Source: Morningstar)

Superinvestors who currently hold positions in Ingredion include:

Cliff Asness – 1,084,965 shares

Donald Yacktman – 891,712 shares

Israel Englander – 207,397 shares

David Einhorn – 164,700 shares

Ray Dalio – 31,864 shares

Ken Griffin – 21,308 shares

Chuck Royce – 8,500 shares

Joel Greenblatt – 5,999 shares

Jeremy Grantham – 3,905 shares

Paul Tudor Jones – 3,766 shares

Jim O’Shaughnessy – 733 shares

For more articles like this, check out our value investing news here.

FREE Stock Screener

Don’t forget to check out our FREE Large Cap 1000 – Stock Screener, here at The Acquirer’s Multiple:

unlimited

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.